ZURA BIO LIMITED Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests
ZURA BIO LIMITED (ZURA) had Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests of $0 as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Including Noncontrolling Interest
us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests · last filed 2026-08-11
- 2026-06-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $0.00.
- 2026-03-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $0.00.
- 2025-12-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $0.00.
- 2025-06-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $11.66M.
| Period end | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-11 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-11 |
| 2025-06-30 | $11.66M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $11.66M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $11.66M 10-Q · filed 2026-08-11 |
| 2024-03-31 | $11.66M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $18.68M 10-Q · filed 2025-05-08 |
| 2022-01-17 | $0.00 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |